Yaping Liu

17PUBLICATIONS
36CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersFlow analysisMedical biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 31, 2026
The m6A-mediated epi-transcriptomic dysregulation drives synaptic dysfunction in fragile X syndrome.

|Apr 10, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.

Ravi Bandaru, Hailu Fu, Haizi Zheng

|Nov 12, 2025
FinaleToolkit: accelerating cell-free DNA fragmentation analysis with a high-speed computational toolkit.

James Wenhan Li, Ravi Bandaru, Kundan Baliga

|Mar 04, 2025
Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study.

Hailu Fu, Kevin Huang, Wen Zhu

|Oct 28, 2024
An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m 6 A- mediated epi-transcriptomic dysregulation underlying synaptic dysfunction.

Lu Lu, Avijite Kumer Sarkar, Lan Dao

|Jul 03, 2024
Downstream-of-gene (DoG) transcripts contribute to an imbalance in the cancer cell transcriptome.

Kouki Abe, Brian Maunze, Pedro-Avila Lopez

Pageof 3

Frequent Collaborators

6 joint publications

Ravi Bandaru

4 joint publications

Hailu Fu

4 joint publications

Zongqi Xia

2 joint publications

James Wenhan Li